Manage Diabetes with GLIMITERIS TRIO 0.3 Combination Therapy

May 23, 2024

GLIMITERIS TRIO 0.3

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg combination of GLIMITERIS TRIO 0.3 marketed as GLIMITERIS TRIO 0.3, is a powerful combination medication used in the management of type 2 diabetes. This combination helps in controlling blood sugar levels effectively through multiple mechanisms of action.

Uses :

  • Type 2 Diabetes Management: Primarily used to manage blood glucose levels in patients with type 2 diabetes.
  • Improves Glycemic Control: Enhances overall glycemic control by targeting different aspects of glucose metabolism.

How to Use :

  • Dosage: Take one tablet of GLIMITERIS TRIO 0.3 daily, preferably with a meal to reduce gastrointestinal side effects.
  • Regular Monitoring: Regularly monitor blood glucose levels to ensure the medication is working effectively.

Mechanism of Action :

  • Voglibose: Delays glucose absorption in the intestine, reducing postprandial blood sugar spikes.
  • Glimepiride: Stimulates the pancreas to release more insulin, thereby lowering blood sugar levels.
  • Metformin Hydrochloride: Decreases glucose production in the liver and improves insulin sensitivity in peripheral tissues.

Side Effects :

  • Hypoglycemia: Risk of low blood sugar levels, especially when combined with other antidiabetic medications.

Precautions :

  • Kidney Function: Regularly monitor kidney function as metformin can affect renal function.
  • Avoid Alcohol: Limit alcohol consumption to reduce the risk of lactic acidosis and hypoglycemia.
  • Consult a Doctor: Consult a healthcare provider if you experience severe side effects or if there is no improvement in blood glucose control.

Storage :

  • Cool, Dry Place: Store GLIMITERIS TRIO 0.3 in a cool, dry place away from direct sunlight.
  • Keep Out of Reach of Children: Ensure the medication is stored safely out of the reach of children.

Conclusion :

The combination of Voglibose 0.3 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg, known as GLIMITERIS TRIO 0.3, offers a comprehensive approach to managing type 2 diabetes. Its multifaceted mechanism of action makes it an effective solution for achieving better glycemic control and improving the quality of life for patients with diabetes.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH